N
Nektar Therapeutics India Private Ltd.
Advancing the treatment of autoimmune disorders, chronic inflammatory conditions and cancer with novel therapies which selectively modulate the immune system.
Country/Area ：India
Company Email ：contact@nektar.com.au
Industry ：HealthcarePharmaceuticals
Company address ：SY. NO. 101/02, LALGADI MALAKPET, GENOME VALLEY SHAMEERPET MANDAR RANGA REDDY DIST, HYDERABAD, TS 500078
Company website ：*****
Company phone ：(415) 482-5300
Established ：-
Company Revenue ：$103,082,000
Number of employees ：11-50
SIC Code ：28283
NAICS Code ：32325
Company News
Nektar Therapeutics (NKTR) Q3 2023 Earnings Call Transcript
Nov 8, 2023
Nektar Therapeutics (NASDAQ:NASDAQ:NKTR) Q3 2023 Earnings Conference Call November 7, 2023 5:00 PM ETCompany ParticipantsVivian Wu - Director, IR and...
Nov 8, 2023
Nektar Therapeutics Reports Third Quarter 2023 Financial ResultsNov 7, 2023
SAN FRANCISCO, Nov. 7, 2023 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the third quarter ended September 30, 2023. Cash and investments in marketable securities at September 30, 2023, were $372.7 million as compared to $505.0 million at...
Nov 7, 2023Nektar to Announce Financial Results for the Third Quarter 2023 on Tuesday, November 7, 2023, After Close of U.S.-Based Financial MarketsOct 31, 2023
SAN FRANCISCO, Oct. 31, 2023 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) will announce its financial results for the third quarter 2023 on Tuesday, November 7, 2023, after the close of U.S.-based financial markets. Howard Robin, President and Chief Executive Officer, will host a...
Oct 31, 2023Nektar Presents New Responder Data for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell Therapy, in Late-Breaking News Oral Presentation at 2023 EADV CongressOct 13, 2023
– Dose-Dependent Efficacy Reported Across All Endpoints for REZPEG Demonstrating a Rapid Onset of Action and Continuing Benefit for 36 Weeks After 12-Week Treatment Period – – New Data Presented Show Encouraging Proportion of Patient-Reported Responder Outcomes for DLQI and POEM Endpoints...
Oct 13, 2023Nektar Therapeutics Announces Two Abstracts Accepted at EADV Congress 2023 for Rezpegaldesleukin, a First-in-Class Selective Regulatory T-cell TherapyOct 2, 2023
– Phase 1b Safety and Efficacy Data for Rezpegaldesleukin in Moderate to Severe Atopic Dermatitis to be Presented in Late-Breaking Oral Presentation – SAN FRANCISCO, Oct. 2, 2023 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) announced today that it will have two presentations for...
Oct 2, 2023Business Info
CIN ：U24239TG2005FTC046253
Registered State ：Telangana
Registrar Of Companies ：RoC-Hyderabad
Category ：Company limited by Shares
Sub Category ：Subsidiary of Foreign Company
Company Class ：Private
Company Status ：Active
Registered Office Address ：Sy.No. 101/2, Lalgadimalakpet Genome Valley, Shamirpet Hyderabad TG IN 500078
Authorized Cap ：300000000.00
Paidup Capital ：293907500.00
Web Summary
Q1: What is the address of Nektar Therapeutics India Private Ltd.?
A1: Unfortunately, the provided text does not mention the specific address of Nektar Therapeutics India Private Ltd.
Q2: What products or medicines are marketed by Nektar Therapeutics?
A2: The text mentions that Nektar Therapeutics markets U.S. Medicines and EU Medicines, but it does not provide a comprehensive list of their products or medicines.
Q3: In which industry is Nektar Therapeutics operating?
A3: Nektar Therapeutics is operating in the biotechnology and pharmaceutical industry.
Q4: What services does Nektar Therapeutics offer?
A4: The text mentions that Nektar Therapeutics offers various services, including Research Platform, Scientific Posters, Presentations, and Publications, as well as Clinical Trials, Expanded Access, Investigator Sponsored Trials, and more.
Q5: How can one contact Nektar Therapeutics?
A5: The provided text does not provide a direct phone number or email address for contacting Nektar Therapeutics. However, it mentions that investors can register for email alerts on the company's website.
Q6: What is the leadership structure of Nektar Therapeutics?
A6: According to the text, Nektar Therapeutics' leadership includes Howard W. Robin as President & Chief Executive Officer, Robert Bacci as Chief People Officer and Head of Quality & Facilities, Jason Barnard as Chief Accounting Officer, and Sandra Gardiner as Chief Financial Officer.
Q7: What is the company's pipeline like?
A7: The text mentions that Nektar Therapeutics has a Pipeline section on its website, but it does not provide detailed information about their current or upcoming products.
Q8: How can one find more information about Nektar Therapeutics' leadership and management team?
A8: According to the provided text, one can find more information about Nektar Therapeutics' leadership and management team by visiting their website and navigating to the "Our Leadership" section.
A1: Unfortunately, the provided text does not mention the specific address of Nektar Therapeutics India Private Ltd.
Q2: What products or medicines are marketed by Nektar Therapeutics?
A2: The text mentions that Nektar Therapeutics markets U.S. Medicines and EU Medicines, but it does not provide a comprehensive list of their products or medicines.
Q3: In which industry is Nektar Therapeutics operating?
A3: Nektar Therapeutics is operating in the biotechnology and pharmaceutical industry.
Q4: What services does Nektar Therapeutics offer?
A4: The text mentions that Nektar Therapeutics offers various services, including Research Platform, Scientific Posters, Presentations, and Publications, as well as Clinical Trials, Expanded Access, Investigator Sponsored Trials, and more.
Q5: How can one contact Nektar Therapeutics?
A5: The provided text does not provide a direct phone number or email address for contacting Nektar Therapeutics. However, it mentions that investors can register for email alerts on the company's website.
Q6: What is the leadership structure of Nektar Therapeutics?
A6: According to the text, Nektar Therapeutics' leadership includes Howard W. Robin as President & Chief Executive Officer, Robert Bacci as Chief People Officer and Head of Quality & Facilities, Jason Barnard as Chief Accounting Officer, and Sandra Gardiner as Chief Financial Officer.
Q7: What is the company's pipeline like?
A7: The text mentions that Nektar Therapeutics has a Pipeline section on its website, but it does not provide detailed information about their current or upcoming products.
Q8: How can one find more information about Nektar Therapeutics' leadership and management team?
A8: According to the provided text, one can find more information about Nektar Therapeutics' leadership and management team by visiting their website and navigating to the "Our Leadership" section.
Customs Data
As a purchaser
As a Supplier
Get the Whole details
Contact
Total found ??? Contacts
All
Boss
Management
Procurement
Other
Get the Whole details
